Avantor AVTR Insider Ownership

NYSE AVTR
$16.67 +0.38 (+2.36%)
As of: Oct 20, 2026 · 1:40 PM EDT

Insider Holdings by Owner

7.53Mn Shares

Insider Ownership Statistics

as of 30 Sep, 2026
Insider Ownership
1.01%
▼-0.0037% pp QoQ
Shares Held by Insiders
6.85Mn
filed for Sep 2026
▼-0.37% QoQ
Shares Outstanding
676.36Mn
676,358,840 shares
Direct Holdings
5.35Mn
Indirect: 1.51Mn
Net Shares Traded (QoQ)
-25.16K
net selling in Sep 2026
Insiders Holding Shares
38
with Form 4 holdings on file

Shares Owned by Insiders

Shares held % of outstanding
Latest —
Average ownership —
Peak ownership —

Shares Purchased/Sold by Insiders

Bought Sold
Latest quarter —
Net over range —
Buying quarters —

Insider Ownership Summary

Across the past 12 months, open-market trades by Avantor insiders were all purchases, totaling $8.69 million (847.5K shares).

Form 4 Holdings

Insiders Holding AVTR

Insiders 38
Shares held 7.53Mn
Of outstanding 1.11%
# Insider Position Direct Indirect Total Share of Insiders Last Filed
1 Michael Stubblefield President Ceo 1,219,013 545,500 1,764,513 23.4% 21 May, 2025
2 Rajiv Gupta Director 780,562 0 780,562 10.4% 05 Apr, 2022
3 Emmanuel Ligner President And Ceo 737,334 0 737,334 9.8% 20 Aug, 2026
4 R. Brent Jones Evp, Chief Financial Officer 419,782 0 419,782 5.6% 25 Feb, 2026
5 Corey Walker President, Vwr Dist. Servs. 384,535 0 384,535 5.1% 22 Jun, 2026
6 Benoit Gourdier Evp, Bioscience Medtech 362,859 0 362,859 4.8% 25 Feb, 2026
7 Mary Blenn Evp, Chief Operating Officer 253,384 0 253,384 3.4% 23 Feb, 2026
8 Claudius Sokenu Evp, Chief Legal Compliance 251,228 0 251,228 3.3% 27 Jul, 2026
9 Brittany Hankamer Evp, Chief Hr Officer 248,864 0 248,864 3.3% 18 Aug, 2026
10 Jonathan M Peacock Director 219,815 0 219,815 2.9% 12 May, 2025
11 Christophe Couturier Evp, Amea 211,271 0 211,271 2.8% 12 Aug, 2025
12 Frederic Vanderhaegen Evp, Americas And Europe 160,735 0 160,735 2.1% 28 Aug, 2023
13 Ludovic Brellier Evp, Bioscience Medtech 146,566 0 146,566 1.9% 05 May, 2026
14 Steven W Eck Svp Chief Accounting Officer 129,593 0 129,593 1.7% 04 Aug, 2026
15 Michael Wondrasch Evp Cio 96,072 0 96,072 1.3% 22 Feb, 2023
16 Gregory T Lucier Director 34,006 60,000 94,006 1.2% 11 May, 2026
17 Justin Miller Evp General Counsel 93,336 0 93,336 1.2% 19 May, 2023
18 Gerard Brophy Evp, Biopharma Production 89,032 0 89,032 1.2% 19 May, 2023
19 James Bramwell Evp Sales, Customer Excellence 86,605 0 86,605 1.1% 28 Feb, 2025
20 Michael Severino Director 85,821 0 85,821 1.1% 11 May, 2026
21 Gregory L Summe Director 83,381 0 83,381 1.1% 11 May, 2026
22 Thomas A Szlosek Evp Cfo 77,489 0 77,489 1.0% 19 May, 2023
23 Joseph R Massaro Director 77,408 0 77,408 1.0% 11 May, 2026
24 Sheri Lewis Evp, Global Ops Supply Chain 70,692 0 70,692 0.9% 03 Jan, 2024
25 Mala Murthy Director 69,479 0 69,479 0.9% 11 May, 2026
26 Randy Lee Stone Evp, Laboratory Solutions 68,105 0 68,105 0.9% 18 Apr, 2024
27 Juan Andres Director 65,480 0 65,480 0.9% 12 May, 2025
28 Lan Kang Director 52,315 0 52,315 0.7% 12 May, 2025
29 Todd W Garner Evp And Cfo 49,688 0 49,688 0.7% 22 Sep, 2026
30 Louise Makin Director 47,140 0 47,140 0.6% 11 May, 2026
31 John Carethers Director 45,858 0 45,858 0.6% 12 May, 2025
32 Kitty Sahin Evp, Strategycorp Development 42,274 0 42,274 0.6% 22 Jul, 2024
33 Meghan Henson Evp, Chief Hr Officer 40,184 0 40,184 0.5% 27 Feb, 2023
34 Christi Shaw Director 36,271 0 36,271 0.5% 15 May, 2023
35 Sanjeev K Mehra Director 33,376 0 33,376 0.4% 11 May, 2026
36 Simon Dingemans Director 31,495 0 31,495 0.4% 11 May, 2026
37 Mark Christopher Murray Evp, Biomaterials At 18,680 0 18,680 0.2% 18 Jan, 2022
38 Matthew S. Holt Director 7,908 0 7,908 0.1% 16 May, 2022

Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.

Form 4 Filings

692 Insider Transactions

Source SEC Form 4
Latest quarter Sep 2026
Download Data
Date Insider Position Transaction Shares Price Value Shares Held After Ownership
21 Sep, 2026 Todd W Garner Evp And Cfo Acquired A 49,688 $0.00 $0 49,688 Direct
21 Sep, 2026 Todd W Garner Evp And Cfo Acquired A 138,632 $0.00 $0 138,632 Direct
18 Aug, 2026 Emmanuel Ligner President And Ceo Disposed F 29,803 $13.33 $397.27K 737,334 Direct
14 Aug, 2026 Brittany Hankamer Evp, Chief Hr Officer Disposed F 181 $13.66 $2.47K 248,864 Direct
31 Jul, 2026 Steven W Eck Svp Chief Accounting Officer Disposed F 1,385 $13.78 $19.09K 129,593 Direct
24 Jul, 2026 Claudius Sokenu Evp, Chief Legal Compliance Disposed F 1,201 $11.44 $13.74K 251,228 Direct
21 Jun, 2026 Corey Walker President, Vwr Dist. Servs. Disposed F 3,010 $9.58 $28.84K 384,535 Direct
07 May, 2026 Gregory T Lucier Director Acquired A 25,270 $0.00 $0 34,006 Direct
07 May, 2026 Louise Makin Director Acquired A 25,270 $0.00 $0 47,140 Direct
07 May, 2026 Joseph R Massaro Director Acquired A 25,270 $0.00 $0 77,408 Direct
07 May, 2026 Mala Murthy Director Acquired A 25,270 $0.00 $0 69,479 Direct
07 May, 2026 Michael Severino Director Acquired A 25,270 $0.00 $0 85,821 Direct
07 May, 2026 Sanjeev K Mehra Director Acquired A 25,270 $0.00 $0 33,376 Direct
07 May, 2026 Simon Dingemans Director Acquired A 25,270 $0.00 $0 31,495 Direct
07 May, 2026 Gregory L Summe Director Acquired A 25,270 $0.00 $0 83,381 Direct
08 May, 2026 Gregory T Lucier Director Acquired P 10,000 $8.32 $83.20K 60,000 Indirect
01 May, 2026 Ludovic Brellier Evp, Bioscience Medtech Acquired A 146,566 $0.00 $0 146,566 Direct
01 May, 2026 Ludovic Brellier Evp, Bioscience Medtech Acquired A 246,002 $0.00 $0 246,002 Direct
01 May, 2026 Simon Dingemans Director Acquired P 25,000 $8.14 $203.50K 25,000 Indirect
03 Apr, 2026 Steven W Eck Svp Chief Accounting Officer Acquired A 31,645 $0.00 $0 130,978 Direct